Sramana Mitra: My next question is from an industry point of view. What are the trends and where do you see open problems that are perhaps not in your product roadmap but are things that you are seeing just because of your deep penetration and insight of the space? Where do you see the problems
Abraham Gutman: Another level of quality analysis that we do is on the meta data in the images. You know how JPEGs have some meta data. It has a little bit of GPS stuff. In a JPEG, you may have a few dozen meta tags, so to speak. In a medical image, you have several
Abrahama Gutman: You have to check the sub-assemblies where they are being assembled and put together into a data submission, which occurs typically every six weeks for a period of three to four years. You should also check that the submission meets the requirements of the charter of the clinical trial. It’s important and is typically done after
Abraham Gutman: We needed to figure out a way of using our infrastructure. It was the same infrastructure as for the eBay of radiology, but I needed to have a way of enabling people to send these images using just a software front-end. There were a number of things that you needed to be able
Abraham Gutman: Pretty soon, I realized that that’s not how medicine works. It’s not arbitrage. This whole notion that people have that most radiology images are leaving the United States and going to India to be read, is absolutely wrong. In the United States, you are required to have three things in order to be
Sramana Mitra: Moving big images is no big deal. Abraham Gutman: I said, “I won’t compress images. Who cares about compressing? There’s a lot of capacity in the ground already. Tell me how big a pipe I need and I’ll just make or lease a pipe. I can move truck loads of images very fast
Clinical trials are hugely expensive for pharmaceutical companies to administer. Abraham Gutman has created a solution to make the process substantially more efficient and offers insights on new entrepreneurial opportunities in the field. Sramana Mitra: Let’s start with introducing our audience to yourself as well as to the company. Abraham Gutman: I’m the founder and